Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.120 | None | 1.000 | 3 | 3 | 2010 | 2012 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.110 | None | 1.000 | 3 | 2 | 2010 | 2012 | ||||||||
|
ribonuclease T2 | 0.682 | 0.615 | 2.7E-04 |
|
disease | 0.110 | None | 1.000 | 3 | 2 | 2010 | 2016 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2010 | 2014 | ||||||||
|
RPGRIP1 like | 0.534 | 0.769 | 4.1E-31 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
forkhead box D3 | 0.587 | 0.692 | 0.58 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.100 | None | 0.833 | 24 | 3 | 1993 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2008 | 2020 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.100 | None | 1.000 | 5 | 5 | 2010 | 2016 | ||||||||
|
arginine-glutamic acid dipeptide repeats | 0.526 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2016 | ||||||||
|
ubiquitin associated and SH3 domain containing A | 0.638 | 0.538 | 1.0E-10 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2016 | ||||||||
|
C1q and TNF related 6 | 0.682 | 0.577 | 9.0E-06 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2010 | 2016 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2010 | 2016 | ||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2012 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2019 | |||||||||
|
thyroglobulin | 0.480 | 0.808 | 2.9E-59 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2016 | ||||||||
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 0.568 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2016 | ||||||||
|
FGFR1 oncogene partner | 0.656 | 0.577 | 6.3E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2012 | ||||||||
|
solute carrier family 1 member 2 | 0.511 | 0.731 | 0.71 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2016 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
EGF like domain multiple 8 | 0.792 | 0.269 | 1.1E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2010 | 2010 | ||||||||
|
Fli-1 proto-oncogene, ETS transcription factor | 0.468 | 0.692 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
solute carrier family 44 member 4 | 0.678 | 0.615 | 1.0E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
DExD-box helicase 39B | 0.641 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 |